Breaking Through Where Cancer Hides
Lumigen Biotech is pioneering antibody-guided nanocomplexes that deliver powerful drugs deep inside tumors, even those shielded by the brain or dense tissue barriers. Our NOVVA™ platform is built to reach cancers that others can’t, creating new possibilities for patients.
Delivering Where Other Treatments Can’t.
Our proprietary NOVVA™ platform is built to break through the barriers that make many cancers, including brain tumors and other aggressive solid tumors, so difficult to treat.
Advancing Treatments of the Future
By pairing proven cancer targets with an advanced antibody-guided nanocomplex platform, Lumigen aims to bring new hope to patients and create lasting value for partners and investors.
